Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Mydecine Innovations Group Inc (MYCOF) Message Board

Study Finds Psilocybin Use Lowers Odds of Being Ar

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 160
(Total Views: 254)
Posted On: 03/01/2022 4:55:15 PM
Avatar
Posted By: NetworkNewsWire
Study Finds Psilocybin Use Lowers Odds of Being Arrested

A new study has linked the use of psilocybin with a reduction in the likelihood of an individual engaging in criminal behavior. Psilocybin is the active compound found in hallucinogenic mushrooms.

Harvard University clinical psychology PhD candidate Grant Jones, the author of the study, stated that his interest in psychedelics grew as the substances gained more attention because of their treatment potential, having demonstrated that they could be used to relieve a number of mental health conditions. Jones explained that the purpose of the research was to investigate the relationship between criminality and psychedelics using population-based survey data, because not many studies on this had been done.

The researchers were especially interested in finding the link between reduced criminal behavior and the use of psychedelics, explaining that prior studies only looked into the link between crime arrests and classic psychedelics as a group.

For their own study, the researchers sought to investigate the link between crime arrest outcomes and a number of classic psychedelic compounds, including mescaline, peyote, LSD and psilocybin. They used data obtained from the National Survey on Drug Use and Health survey, which gathers information on mental health outcomes and drug use in the United States annually.

The researchers conducted an analysis of this data, which comprised of a sample made up of more than 211,000 adults who filled out the survey in the period between 2015 and 2019. The survey asked respondents if they had been arrested for burglary, larceny, robbery, motor vehicle theft, serious violent offenses, assault/battery, possession of stolen goods, fraud, vandalism, public drunkenness, drug possession/sale and DUIs, among other crimes.

The researchers discovered that individuals who used psilocybin reported lower odds of being arrested for DUIs, serious violence, assault/battery, robbery, burglary, larceny and miscellaneous crimes. The use of peyote was also linked to lower rates of being arrested for DUIs and motor vehicle theft.

The researchers also found that LSD was the most commonly used drug, noting that its use wasn’t associated with criminal arrests. However, the use of marijuana, cocaine and heroin was linked to significantly higher chances of criminal arrests.

The study’s findings offer evidence that the use of psilocybin corresponds to lower chances of criminal arrest, even after accounting for a number of demographic factors, including level of education, class and race. In their report, the researchers highlight that the findings should be viewed as a preliminary link between lower chances of criminal arrests and the use of psilocybin, noting that more research is needed to better understand this association.

The study’s findings were reported in the “Journal of Psychopharmacology.”

The findings of this study aren’t surprising to a large extent, given the many beneficial effects being documented about psilocybin and how companies such as Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are devoting significant time and funds towards developing therapeutic products from this and other psychedelic compounds in a bid to address the treatment needs of people battling addiction and other mental health issues.

NOTE TO INVESTORS: The latest news and updates relating to Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are available in the company’s newsroom at https://ibn.fm/MYCOF

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer




(0)
(0)




Mydecine Innovations Group Inc (MYCOF) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us